Dexcom
company that develops, manufactures and distributes continuous glucose monitoring systems
DXCM Nasdaq
ISIN US2521311074 SEC CIK 1093557 LEI 549300YSK3QDSFR5EU59
Follow Dexcom
Weekly email: filings, results
Revenue, last quarter
$1.3B
+11.2% vs same quarter last year
Net income
$275.1M
−3.1% vs same quarter last year
EPS, diluted
$0.72
+2.9% vs same quarter last year
Operating cash flow
$325.6M
−50.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $4.7B | $836.3M |
| FY24 | $4B | $576.2M |
| FY23 | $3.6B | $541.5M |
| FY22 | $2.9B | $341.2M |
| FY21 | $2.4B | $216.9M |
| FY20 | $1.9B | $549.7M |
| FY19 | $1.5B | $101.1M |
| FY18 | $1B | −$127.1M |
| FY17 | $718.5M | −$50.2M |
| FY16 | $573.3M | −$65.6M |
| FY15 | $402M | −$57.6M |
| FY14 | $259.2M | −$22.4M |
| FY13 | $160M | −$29.8M |
| FY12 | $99.9M | −$54.5M |
| FY11 | $76.3M | −$44.7M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 60.1% | 19.6% | 17.9% |
| FY24 | 60.5% | 14.9% | 14.3% |
| FY23 | 63.2% | 16.5% | 14.9% |
| FY22 | 64.7% | 13.4% | 11.7% |
| FY21 | 68.6% | 10.9% | 8.9% |
| FY20 | 66.4% | 15.5% | 28.5% |
| FY19 | 63.1% | 9.6% | 6.8% |
| FY18 | 64.4% | −18.1% | −12.3% |
| FY17 | 68.5% | −5.9% | −7% |
| FY16 | 66% | −11.1% | −11.4% |
| FY15 | 69.3% | −14.2% | −14.3% |
| FY14 | 68% | −8.3% | −8.6% |
| FY13 | 62.6% | −18.1% | −18.6% |
| FY12 | 46.6% | −55.8% | −54.6% |
| FY11 | 47.1% | −58.7% | −58.6% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $1.1B |
| FY24 | $630.7M |
| FY23 | $511.9M |
| FY22 | $304.7M |
| FY21 | $53.3M |
| FY20 | $276.6M |
| FY19 | $134.5M |
| FY18 | $56.1M |
| FY17 | $26M |
| FY16 | $500K |
| FY15 | $15.7M |
| FY14 | $7.4M |
| FY13 | −$5.5M |
| FY12 | −$42.6M |
| FY11 | −$38.1M |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | $500M |
| FY24 | $750M |
| FY23 | $688.7M |
| FY22 | $557.7M |
| FY21 | $0 |
| FY20 | $0 |
| FY19 | $0 |
| FY18 | $100M |
| FY17 | $0 |
| FY16 | $0 |
| FY15 | - |
| FY14 | - |
| FY13 | - |
| FY12 | - |
| FY11 | - |
- Dexcom
- Healthcare median
Show the numbers
| Year | Dexcom | Healthcare median |
|---|---|---|
| FY25 | 17.9% | −30.6% |
| FY24 | 14.3% | −47% |
| FY23 | 14.9% | −58% |
| FY22 | 11.7% | −80.4% |
| FY21 | 8.9% | −71.9% |
| FY20 | 28.5% | −62.2% |
| FY19 | 6.8% | −46.3% |
| FY18 | −12.3% | −49.6% |
| FY17 | −7% | −45.9% |
| FY16 | −11.4% | −36% |
| FY15 | −14.3% | −38.4% |
| FY14 | −8.6% | −35.5% |
| FY13 | −18.6% | −37.1% |
| FY12 | −54.6% | −29.1% |
| FY11 | −58.6% | −27.9% |